#1 Clinical Trials Search in Europe

Rifabutin

Rifabutin is an antibiotic medication that has shown promise in treating tuberculosis (TB) and other mycobacterial infections, particularly in patients with HIV. This article summarizes key findings from several clinical trials investigating the use of rifabutin for various mycobacterial infections, its interactions with antiretroviral medications, and its potential advantages over other similar drugs like rifampicin in certain patient populations.

Table of Contents

What is Rifabutin?

Rifabutin, also known by its brand name Mycobutin, is an antibiotic medication used to treat various bacterial infections, particularly those caused by mycobacteria[1]. It belongs to a class of drugs called rifamycins, which are known for their effectiveness against certain types of bacteria[2].

Rifabutin is a red-violet powder that comes in capsule form for oral administration. Each capsule typically contains 150 mg of rifabutin along with other inactive ingredients[2].

What Conditions Does Rifabutin Treat?

Rifabutin is used to treat several conditions, including:

  • Mycobacterium avium complex (MAC) infections: This is a group of bacteria that can cause serious infections in people with weakened immune systems, particularly those with advanced HIV/AIDS[3].
  • Tuberculosis (TB): Rifabutin is sometimes used as an alternative to other TB medications, especially in patients who are also taking HIV medications[4].
  • Non-tuberculous mycobacterial (NTM) infections: These are infections caused by mycobacteria other than those that cause tuberculosis[5].
  • Prevention of MAC disease: In people with advanced HIV infection, rifabutin is used to prevent the development of MAC disease[1].

How Does Rifabutin Work?

Rifabutin works by inhibiting bacterial RNA synthesis. This means it stops bacteria from producing the proteins they need to survive and multiply. By doing this, rifabutin can either kill the bacteria or stop them from growing, allowing the body’s immune system to fight off the infection more effectively[2].

Dosage and Administration

The dosage of rifabutin can vary depending on the condition being treated, the patient’s age, weight, and other factors. Here are some general guidelines:

  • For prevention of MAC disease in HIV patients: The usual adult dose is 300 mg once daily[1].
  • For treatment of tuberculosis: The dose can range from 150 mg to 450 mg once daily, depending on whether the patient is also taking certain HIV medications[1].
  • For treatment of non-tuberculous mycobacterial diseases: The usual adult dose is 300 mg once daily[1].

Rifabutin is usually taken orally (by mouth) as a capsule. It can be taken with or without food, but taking it with food may help reduce stomach upset[2].

Side Effects and Safety

Like all medications, rifabutin can cause side effects. Some of the most common side effects include:

  • Nausea and vomiting
  • Stomach pain
  • Diarrhea
  • Rash
  • Changes in liver function tests
  • Neutropenia (low white blood cell count)

More serious but less common side effects can include:

  • Uveitis: This is inflammation of the middle layer of the eye. It’s more likely to occur with higher doses of rifabutin[6].
  • Severe skin reactions
  • Liver problems

It’s important to report any unusual symptoms to your healthcare provider promptly[1].

Drug Interactions

Rifabutin can interact with many other medications, particularly HIV medications. Some key points about drug interactions include:

  • Rifabutin is often used instead of rifampicin in HIV patients because it has fewer interactions with antiretroviral drugs[2].
  • However, rifabutin can still interact with some HIV medications, particularly protease inhibitors like lopinavir/ritonavir. These interactions may require dose adjustments[6].
  • Rifabutin can affect the levels of other medications in the body, potentially making them less effective or increasing side effects[7].

Always inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements[7].

Use in Special Populations

Special considerations may be needed for certain groups:

  • Children: Dosing in children is typically based on weight. There’s ongoing research to determine the best dosing strategies for children, especially those also taking HIV medications[2].
  • Pregnant women: The safety of rifabutin during pregnancy hasn’t been fully established. Discuss the risks and benefits with your healthcare provider if you’re pregnant or planning to become pregnant.
  • Elderly patients: Older adults may be more sensitive to the effects of rifabutin and may require closer monitoring.

Ongoing Research

Research on rifabutin is ongoing, particularly in the context of HIV and tuberculosis co-infection. Some areas of current research include:

  • Comparing the effectiveness and safety of rifabutin versus rifampicin in HIV patients with tuberculosis[4].
  • Investigating the optimal dosing of rifabutin when used with different HIV medications[6].
  • Studying the use of rifabutin in treating drug-resistant mycobacterial infections[5].

These ongoing studies aim to improve the treatment of mycobacterial infections, particularly in patients with HIV/AIDS[4][6][5].

Aspect Details
Main Uses Treatment of tuberculosis, prevention and treatment of MAC infections in HIV patients
Advantages Fewer drug interactions with antiretroviral medications compared to rifampicin
Dosing Typically 150-300 mg daily or 150 mg three times weekly, depending on other medications
Patient Groups Adults and children with HIV/AIDS, particularly those on certain antiretroviral regimens
Key Outcomes Improved treatment of TB in HIV patients, prevention of MAC infections, potential for better coordination with HIV medications
Safety Considerations Monitoring for uveitis, neutropenia, and liver function changes; dose adjustments may be needed

FAQ

  • What is rifabutin used to treat? Rifabutin is primarily used to treat tuberculosis (TB) and prevent or treat Mycobacterium avium complex (MAC) infections in patients with HIV/AIDS. It can also be used for other nontuberculous mycobacterial infections.
  • How does rifabutin compare to rifampicin? Rifabutin has fewer drug interactions with antiretroviral medications compared to rifampicin, making it a preferred option for treating TB in HIV patients on certain antiretroviral regimens. It may allow for more flexible dosing of HIV medications.
  • What is the typical dosage of rifabutin? The dosage of rifabutin can vary depending on the specific condition being treated and other medications being taken. Common dosages range from 150-300 mg daily or 150 mg three times weekly when used with certain HIV medications.
  • What are the main side effects of rifabutin? Common side effects may include nausea, vomiting, stomach pain, rash, and changes in liver function tests. More serious but rare side effects can include uveitis (eye inflammation) and neutropenia (low white blood cell count).
  • Can rifabutin be used in children with HIV and TB? Yes, rifabutin can be used in children with HIV and TB. However, the optimal dosing for children is still being studied. Some trials have investigated dosing of 5 mg/kg three times weekly in young children taking certain antiretroviral medications.

Ongoing Clinical Trials on Rifabutin

  • Study on the Effectiveness of Clofazimine and Drug Combination for Treating Mycobacterium abscessus Lung Disease in Adult Patients

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study Comparing Rifabutin and Rifampicin for Adults with Staphylococcal Prosthetic Joint Infection Using DAIR Strategy

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France

Glossary

  • Mycobacterium avium complex (MAC): A group of bacteria that can cause serious infections in people with weakened immune systems, such as those with advanced HIV/AIDS.
  • Antiretroviral therapy (ART): Medications used to treat HIV infection, typically consisting of a combination of different drugs.
  • Pharmacokinetics: The study of how drugs are absorbed, distributed, metabolized, and eliminated by the body.
  • Drug-drug interaction: When one medication affects the activity of another medication when both are taken together, potentially altering their effectiveness or side effects.
  • Uveitis: Inflammation of the middle layer of the eye, which can be a rare side effect of high-dose rifabutin.
  • Neutropenia: An abnormally low count of neutrophils, a type of white blood cell important for fighting infections.
  • Boosted protease inhibitor (bPI): A type of HIV medication that is given with a small dose of another drug (usually ritonavir) to boost its levels in the body.
  • Sputum conversion: When a person with active TB stops being infectious, typically measured by a change from positive to negative sputum cultures.

References

  1. https://clinicaltrials.gov/study/NCT00810446
  2. https://clinicaltrials.gov/study/NCT01259219
  3. https://clinicaltrials.gov/study/NCT00001995
  4. https://clinicaltrials.gov/study/NCT03478033
  5. https://clinicaltrials.gov/study/NCT03164291
  6. https://clinicaltrials.gov/study/NCT01663168
  7. https://clinicaltrials.gov/study/NCT00925535